Inhalation Anesthetics Market Size: Opportunities, Current Trends And Industry Analysis By 2020-2030

By Product (Desflurane, Sevoflurane, Isoflurane, and Other Products), By End User (Hospitals and Ambulatory Surgical Centers), By Application (Induction and Maintenance), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030


Introduction:
Inhalational anesthetics help to avoid excessive dosage and keeps the patient’s autonomic functions intact. These drugs are eradicated through lungs and they have minor chances of accumulation in the body. The most common inhalational anesthetics are desflurane, sevoflurane, and nitrous oxide. Among these, sevoflurane is the most common due to its rapid onset of action and the point that patients recover quickly from it. Inhalational anesthetics lead to respiratory depression, reduction in arterial blood pressure and cerebral metabolic demand, and growth in cerebral blood flow.
Drivers and Restraints:
A growing number of surgical procedures requiring anesthesia, rising usage of inhalable anesthetics, and technological advancements about anesthesia delivery devices in the emerging markets, such as China and India are the major factors driving the growth of the target market. According to the Centers of Disease Control and Prevention (CDC) in 2017, more than 51 million inpatient surgeries and 53 million outpatient surgeries were performed in the U.S. Increasing number of surgeries in Asia-Pacific (especially in China and India), mainly because of the high patient population levels is also boosting growth of the global market. Moreover, technological advancements in the anesthesia techniques and machines are also propelling the adoption rate of inhalation anesthetics. For instance, Sedana Medical advanced an anesthetic delivery system, AnaConDa, which allows the efficient and safe delivery of volatile anesthetics, such as sevoflurane or isoflurane, to the invasively ventilated patients. However, the launch of generic counterparts of inhalation anesthetics is one of the major hampering factors for the growth of the global market. Introduction of generics leads to a sharp decline in the usage of patented products. Furthermore, generic drugs also lead to pricing pressure on branded counterparts, which in turn, restricts the global market growth, in terms of revenue.
Segmentation:
The global inhalation anesthetics market is segmented based on the product, end-user, application, and region.
Based on the product, the global inhalation anesthetics market is segmented into desflurane, sevoflurane, isoflurane, and other products. Based on end-user, the target market is classified into hospitals and ambulatory surgical centres. Based on the application, the target market is classified into induction and maintenance.

Contact Us:
Mr. Alex (Sales Manager)
Prophecy Market Insights
Phone: +1 860 531 2701
Connetct With Us:-

facebook 
linkedin
Twitter 

Comments

Post a Comment

Popular posts from this blog

North America Depression Therapeutics Market Analysis, Dynamics, Forecast and Supply Demand 2019-2029

Image
By Drug Type (Selective Serotonin Reuptake Inhibitors (SSRIs), Selective Norepinephrine Reuptake Inhibitors (SNRIs), and Others (Serotonin Modulators, Tricyclic & Tetracyclic Antidepressant and, Atypical Antidepressant)), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Country (U.S. and Canada) - Market Trends, Analysis, and Forecast till 2029 North America depression therapeutics market report published by Prophecy Market Insights offers holistic view of various influencing factors and aims to answer all the target market related questions. High awareness regarding depression and availability of drugs and therapies is the major driver for the target market growth. However, the patent cliff has caused a decline in the growth rates of the market. For instance, according to a data published by National Alliance on Mental Illness in 2019, 64.1% of U.S. adults with serious mental illness received treatment in 2018. However, patent cli...
Read more

Sickle Cell Disease Treatment Market With Four Main Geographies And Their Countries

Image
By Product (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobin meters, Other Products), By Reagents (Coagulation Reagents, Flow Cytometer Reagents, Immuno-hematology Reagents, and Other Reagents), By Application (Drug Testing and Auto-Immune Disease), By End User (Hospitals, Clinical Testing Institutes, Patient Self-testing, and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030 Introduction: The pipeline for sickle cell disease comprises strong pharmaceutical companies with novel therapies in the late stages of clinical trials and various mid and small pharmaceutical companies with early-stage pipeline drugs. The strong efficacy of these drugs in the early stages of clinical trials has led to a positive opinion from the regulatory bodies. Thus, helping the vendors with the quick development of these drugs. Drivers and R...
Read more

Enasidenib Drugs Market Growth by 2029: PMI

Image
Global enasidenib drugs market report published by Prophecy Market Insights offers holistic view of various influencing factors and aims to answer all the target market related questions. The research scope provides comprehensive market size, and other in-depth market information details such as, market growth supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services advancements and launches, product/services related regulations overview, and recent developments for the mentioned forecast period. In addition, the report provides key examination of market players operating in the specific market and analysis and outcomes related with the target market for more than 20 countries. In the current research scope 2018 is considered as base year and 2019 is estimated year for market value/volume calculations. The report offers market estimates for the forecast period – 2019 to 2029. The report provides factual inputs...
Read more